Cancer drug shows promise for treating scleroderma

Monday, March 28, 2011 - 09:31 in Health & Medicine

A drug approved to treat certain types of cancer has shown promising results in the treatment of patients with scleroderma, according to results from an open-label Phase II trial. While the drug's efficacy must be demonstrated in a Phase III trial, the gold standard for testing a drug, researchers are optimistic that Gleevec could potentially be a weapon against the chronic connective tissue disease for which a treatment has remained elusive.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net